Meng Hu
United States Food and Drug Administration
ORCID: 0000-0003-2719-3263Also affiliated with Center for Drug Evaluation and Research, China Mobile (China), Shenzhen University, Northeast Normal University, Tianjin University of Finance and Economics, Shenzhen Nanshan Center for Chronic Disease Control
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 13 papers. Top paper: “Factors that have an Impact on Abbreviated New Drug Application (ANDA) Submissions”.
Matthew Rosenberg, Andreas Schick, Meng Hu, Zhong Wang, Andrew Babiskin +3 more
Mark Sale, Keith Nieforth, Kristin L. Bigos, James C. Craig, Fenggong Wang +5 more
Meng Hu, John Fuerst
Meng Hu, John Fuerst
Meng Hu, John Fuerst
Meng Hu, John Fuerst
Meng Hu, John Fuerst
Meng Hu, John Fuerst
Meng Hu, John Fuerst
Meng Hu, John Fuerst
Mark Sale, Keith Nieforth, James C. Craig, Fenggong Wang, David B. Solit +5 more
Yuqing Gong, Andrew Babiskin, Meng Hu, Youssef M. Mousa, Ross Walenga +9 more
Steven G. Chopski, Jae Hoon Lee, Fenggong Wang, Meng Hu, Andrew Babiskin +3 more